Please login to the form below
liposomal irinotecan
This page shows the latest liposomal irinotecan news and features for those working in and with pharma, biotech and healthcare.
Shire offloads oncology unit to Servier for $2.4bn
The Dublin-based company said the deal covers its already-marketed drug Oncaspar (pergaspargase) for acute lymphoblastic leukaemia (ALL), as well as ex-US rights to pancreatic cancer therapy Onivyde (irinotecan ... pegylated liposomal formulation) and
Latest news
-
NICE knocks-back Shire's pancreatic cancer drug Onivyde
NICE has ruled that Shire’s pancreatic cancer drug Onivyde (pegylated liposomal irinotecan) is not a cost-effective use of NHS resources. ... NICE said in a statement: “Although this analysis was subject to considerable uncertainty, the committee was
-
Ipsen buys cancer business from stripped down Merrimack
The deal includes Onivyde (liposomal irinotecan) and Merrimack's generic version of Doxil (liposomal doxorubicin), as well as the manufacturing and commercial operations supporting the two products.
-
Shire wins EU licence for pancreatic cancer drug Onivyde
EU. Authorised as a second-line combination therapy, Onivyde (pegylated liposomal irinotecan hydrochloride trihydrate) will be administered with 5-fluorouracil (5-FU) and leucovorin (LV) in adult patients who have progressed
-
HIV prevention pill heads July CHMP recommendations
The CHMP also gave a positive opinion for Shire's Onivyde (pegylated irinotecan liposomal formulation) for the treatment of metastatic adenocarcinoma of the pancreas, in combination with 5-fluorouracil and leucovorin,
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
Accelerating innovation
At the start of this year it acquired Merrimack’s oncology business, including Onivyde (liposomal irinotecan), for $575m.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Business Unit Head, Medical Communications, London
-
Excellent package
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Moving annual total (MAT)
- MaxCyte gets green light for solid tumour cell therapy
- Brexit rebels win vote on European Medicines Agency alignment
- Positive mid-stage trial gives Allergy’s investors some welcome relief
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
- Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO
- Ashfield Meetings & Events welcomes largest intake of students in seventh year of undergraduate placement scheme
- AstraZeneca joins Merck in Brexit stockpiling effort
PMHub
FCB Halesway
A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
